Treating neurodegenerative disease with tyrosine kinase inhibitors
Charbel Moussa discusses his exciting work into the use of FDA approved tyrosine kinase inhibitors to clear toxic neuronal proteins via autophagy.
Charbel Moussa discusses his exciting work into the use of FDA approved tyrosine kinase inhibitors to clear toxic neuronal proteins via autophagy.
This review discusses the evidence linking arterial stiffness, hypertension and brain structural abnormalities in older adults.
A modified version of Raman Spectroscopy has revealed an unexpected structure of amyloid beta.
Many previous findings suggest that understanding the causal relationship between the sleep–wake cycle and Alzheimer’s disease pathologies will provide novel insight into the pathophysiology of Alzheimer’s. This article explores the hypotheses.
An early precursor of the amyloid beta peptide, ßCTF, has been found to initiate a number of processes that can lead to the loss of neurons critical for memory formation in early Alzheimer’s disease.